TSG-6 - a double-edged sword for osteoarthritis (OA)

Area of Science:

• Biochemistry
• Molecular Biology
• Rheumatology

Background:

• Osteoarthritis (OA) is a degenerative joint disease characterized by cartilage breakdown and inflammation.
• The role of Tumor necrosis factor-alpha-stimulated gene/protein 6 (TSG-6) in OA pathogenesis is not fully understood.
• TSG-6 is an inflammatory mediator involved in extracellular matrix (ECM) regulation.

Purpose of the Study:

• To investigate the mechanisms linking TSG-6 to osteoarthritis progression.
• To determine the association between TSG-6 activity and inflammatory mediators in OA synovial fluid.
• To examine the impact of TSG-6 on cartilage ECM assembly.

Main Methods:

• Quantification of TSG-6-mediated heavy chain (HC) transfer (TSG-6 activity) and inflammatory mediators in knee OA synovial fluids.
• Analysis of TSG-6 and Inter-alpha-Inhibitor (IαI) component expression in human tibial and meniscal cartilage using qRT-PCR and immunohistochemistry (IHC).
• Evaluation of primary chondrocyte gene expression and hyaluronan (HA)-aggrecan binding assays to assess ECM assembly.

Main Results:

• TSG-6 activity showed a significant association with multiple inflammatory mediators (e.g., TIMP-1, MMP3, IL-6) in OA synovial fluid.
• TSG-6 was highly expressed in damaged cartilage and cytokine-treated chondrocytes, but IαI components were minimally expressed within cartilage.
• TSG-6 impaired HA-aggrecan assembly, though HA-HC formation partially mitigated this effect.

Conclusions:

• TSG-6 activity serves as a global inflammatory biomarker in knee OA synovial fluid.
• Limited penetration of IαI into cartilage restricts TSG-6 activity to the surface, potentially leading to unopposed TSG-6 in deeper regions.
• Unopposed TSG-6 may inhibit matrix assembly, contributing to futile synthesis and increased OA progression risk.